Clinical Trial

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment

Study acronym: EUGENIE
Recruiting
View on ClinicalTrials.gov →
Summary
EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between molecular classification and disease stage and evaluating if and how disease stage in each of the molecular subgroups associates with prognosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-02.
Trial Details
NCT Number NCT06354738
Lead Sponsor University Hospital, Gasthuisberg
Collaborators: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University Medical Centre Maribor
Conditions Endometrial Cancer
Enrollment 1,000 participants
Start Date 2023-01-16
Primary Completion 2028-11-01 (estimated)
Study Completion 2028-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-17